The anti-dementia drug candidate, (−)-clausenamide, improves memory impairment through its multi-target effect
Keywords: Chirality; Clausenamide; Dementia; Long-term potentiation; Signaling pathway; Calcium6-OHDA, 6-hydroxyldopamine; ACE, acetylcholinesterase; ACh, acetylcholine; AD, Alzheimer's disease; AUC0–12 h, 0–12 h area under curve; APP, amyloid precursor protein; AP